Delivery Order SPE2DB24D1205-SPE2DB25FCWMZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a contract ceiling value of $23,977.17. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units, with a ceiling value of $3,136.98. This contract employs firm fixed-price pricing and is scheduled for completion by June 13, 2025. The award is unset-aside and represents a competitively awarded delivery order under AmerisourceBergen's existing federal procurement framework. The place of performance is located in...
- The Defense Logistics Agency awarded a $10,781.30 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price contract, with an ultimate completion date of July 25, 2025, represents a single delivery order under the company's broader pharmaceutical supply agreement. The award utilizes no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,457.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. The delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $6,717.68. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The order is scheduled for ultimate completion on August 15, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $8,194.35 under a firm fixed-price contract. This non-competitive delivery order represents a continuation of ongoing pharmaceutical supply services to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $8,588.52. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for ultimate completion by August 19, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $11,802.52. This firm fixed-price delivery order, with an ultimate completion date of May 13, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $51,243.85. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCWMZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract ceiling value of $7,330.39. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for completion by May 7, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency, AmerisourceBergen Drug Corp supplies critical pharmaceutical products and medical commodities to support military and federal healthcare systems worldwide. The company's federal contract portfolio demonstrates extensive capability in delivering diverse pharmaceutical products across multiple therapeutic domains, supporting entities including the Defense Health Agency and U.S. Coast Guard through this comprehensive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 5/6/25 |